In a recent research being taken out by a group of researchers from University of Glasgow, UK, it has been revealed that statins also reduces the risk of pancreatitis among patients, who have raised triglyceride levels.

In order to reach at the above given result, the study researchers said that they assessed 28 previous studies, which included 19,000 patients. Lead researcher Dr. David Preiss explained that they found that patients witnessed 20% reduced risk of pancreatitis with statins.

However, on the other hand, they saw 40% rise in the risk when patients took fibrates, a group of drugs that is normally recommended for patients having increased blood fat levels.

Preiss was of the view that the risk is possible, as the drug increases the chance of suffering from gallstones. So, through their study, which has been published in the Journal of the American Medical Association, they have challenged the studies, which have concluded that fibrates is a safe option for patients having increased blood fat levels.

In contrast to the prevailing views, they would like to lend their support to statins drugs. "Statins appear to be a better option, not only because they reduce the risk of heart attacks but also because they may reduce pancreatitis risk", said Preiss.